Alex Anetakis, MD, MBA

Senior Advisor

Alex Anetakis, MD, MBA, joined UPMC Enterprises in March 2018, and serves as a physician advisor to the Translational Sciences team at UPMC Enterprises, with focus on ophthalmology-related investments. Dr. Anetakis is a vitreo-retinal surgeon who completed his training in 2006 and was initially in private practice in South Carolina for two years prior to joining UPMC’s Department of Ophthalmology in 2008. He has special interests in age-related macular degeneration, diabetic retinopathy, and diseases of the vitreo-retinal interface. Dr. Anetakis graduated from Northeastern Ohio, College of Medicine and completed his MBA at the Tepper School of Business at Carnegie Mellon University.

More Team Members

Meet the Whole Team

James Bauersmith, JD, MS

Translational Sciences

Vice President, Translational Sciences

Clapton Dias, BPharm, PhD

Translational Sciences

Vice President, Head of Portfolio Development

Jessica Furnier, MHA

Translational Sciences

Senior Director of Operations, Translational Sciences

Rob Hartman, PhD

Translational Sciences

Senior Director, Translational Sciences

Julian Hassinger, PhD

Translational Sciences

Associate, Translational Sciences

Matthias Kleinz photo

Matthias Kleinz, DVM, PhD

Leadership Translational Sciences

Senior Vice President, Translational Sciences

Rob Lin, PhD, CFA

Translational Sciences

Vice President, Program Management

John Lowman

Translational Sciences

Manager, Portfolio Development

JoAnn Lucibello

Translational Sciences

Project Administrator

Anna Mamo, MS, MBA

Translational Sciences

Director, Translational Sciences

Joe Pohl, JD

Translational Sciences

Executive In Residence

Chris Stern, PhD

Translational Sciences

Senior Director, Translational Sciences

Socrates Zacharias

Translational Sciences

Senior Director, Translational Sciences